Cardiac Tissue-Restricted Deletion of Plakoglobin Results in Progressive Cardiomyopathy and Activation of β-Catenin Signaling
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Mutations in the plakoglobin (JUP) gene have been identified in arrhythmogenic right ventricular cardiomyopathy (ARVC) patients. However, the mechanisms underlying plakoglobin dysfunction involved in the pathogenesis of ARVC remain poorly understood. Plakoglobin is a component of both desmosomes and adherens junctions located at the intercalated disc (ICD) of cardiomyocytes, where it functions to link cadherins to the cytoskeleton. In addition, plakoglobin functions as a signaling protein via its ability to modulate the Wnt/β-catenin signaling pathway. To investigate the role of plakoglobin in ARVC, we generated an inducible cardiorestricted knockout (CKO) of the plakoglobin gene in mice. Plakoglobin CKO mice exhibited progressive loss of cardiac myocytes, extensive inflammatory infiltration, fibrous tissue replacement, and cardiac dysfunction similar to those of ARVC patients. Desmosomal proteins from the ICD were decreased, consistent with altered desmosome ultrastructure in plakoglobin CKO hearts. Despite gap junction remodeling, plakoglobin CKO hearts were refractory to induced arrhythmias. Ablation of plakoglobin caused increase β-catenin stabilization associated with activated AKT and inhibition of glycogen synthase kinase 3β. Finally, β-catenin/TCF transcriptional activity may contribute to the cardiac hypertrophy response in plakoglobin CKO mice. This novel model of ARVC demonstrates for the first time how plakoglobin affects β-catenin activity in the heart and its implications for disease pathogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244 · cited 5×
“To determine whether PKB/AKT activity was increased in PG CKO hearts, we performed a Western blot assay using a phospho-specific PKB/AKT antibody.”
BackgroundInfluentialGarcia-Gras, E. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27751 · Cited by 623
A New Diagnostic Test for Arrhythmogenic Right Ventricular Cardiomyopathy
Asimaki, A., Tandri, H., Huang, H., Halushka, M. K., Gautam, S., Basso, C., Thiene, G., Tsatsopoulou, A., Protonotarios, N., McKenna, W. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808138 · Cited by 456
Kirchhof, P., Fabritz, L., Zwiener, M., Witt, H., Schäfers, M., Zellerhoff, S., Paul, M., Athai, T., Hiller, K.-H., Baba, H. A., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.624502 · Cited by 429
Li, J., Patel, V. V., Kostetskii, I., Xiong, Y., Chu, A. F., Jacobson, J. T., Yu, C., Morley, G. E., Molkentin, J. D., & Radice, G. L. (2005) · Circulation Research · doi:10.1161/01.res.0000181132.11393.18 · Cited by 223
Self-citationPilichou, K., Remme, C. A., Basso, C., Campian, M. E., Rizzo, S., Barnett, P., Scicluna, B. P., Bauce, B., van den Hoff, M. J. B., de Bakker, J. M. T., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090641 · Cited by 210
Cited by
Arrhythmogenic Right Ventricular Cardiomyopathy
Corrado, D., Link, M. S., & Calkins, H. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1509267 · Cited by 736
van der Zwaag, P. A., van Rijsingen, I. A. W., Asimaki, A., Jongbloed, J. D. H., van Veldhuisen, D. J., Wiesfeld, A. C. P., Cox, M. G. P. J., van Lochem, L. T., de Boer, R. A., Hofstra, R. M. W., et al. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs119 · Cited by 465
Mechanotransduction in Cardiac Hypertrophy and Failure
Lyon, R. C., Zanella, F., Omens, J. H., & Sheikh, F. (2015) · Circulation Research · doi:10.1161/circresaha.116.304937 · Cited by 344
Molecular mechanisms of arrhythmogenic cardiomyopathy
Austin, K. M., Trembley, M. A., Chandler, S. F., Sanders, S. P., Saffitz, J. E., Abrams, D. J., & Pu, W. T. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0200-7 · Cited by 262
Pathophysiology of arrhythmogenic cardiomyopathy
Basso, C., Bauce, B., Corrado, D., & Thiene, G. (2012) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2011.173 · Cited by 253
Trim32 reduces PI3K–Akt–FoxO signaling in muscle atrophy by promoting plakoglobin–PI3K dissociation
Cohen, S., Lee, D., Zhai, B., Gygi, S. P., & Goldberg, A. L. (2014) · Journal of Cell Biology · doi:10.1083/jcb.201304167 · Cited by 103
“Plakoglobin and -catenin can function together in regulating gene transcription (Zhurinsky et al., 2000a,b; Winn et al., 2002; Armstrong et al., 2006; Li et al., 2011), and possibly -catenin may also be regulated by Trim32.”
BackgroundCardiac mesenchymal stromal cells are a source of adipocytes in arrhythmogenic cardiomyopathy
Sommariva, E., Brambilla, S., Carbucicchio, C., Gambini, E., Meraviglia, V., Dello Russo, A., Farina, F. M., Casella, M., Catto, V., Pontone, G., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv579 · Cited by 101
“It has been suggested that defective desmosomes(14) cause stretchinduced cardiomyocyte death(15) and impair intracellular signaling that determines cell fate.(16,17) As a consequence, a cell differentiation hypothesis has been formulated to explain the fibro-adipose replacement, involving the inhibition of canonical W…”
BackgroundSwope, D., Cheng, L., Gao, E., Li, J., & Radice, G. L. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06188-11 · Cited by 91
“Adult MHC/MerCreMer; PG mice were administered tamoxifen (Tam) to induce deletion of the PG gene specifically in the myocardium as previously reported (31).”
BackgroundMethodInfluentialSelf-citationNuclear signaling from cadherin adhesion complexes
McCrea, P. D., Maher, M. T., & Gottardi, C. J. (2015) · Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2014.11.018 · Cited by 85
“Conversely, the conditional removal of plakoglobin from the mouse heart leads to a decrease in desmosomal proteins and a coincident increase in β-catenin stabilization and Wnt signaling (Li et al., 2011).”
BackgroundWnt/β-catenin pathway in arrhythmogenic cardiomyopathy
Lorenzon, A., Calore, M., Poloni, G., De Windt, L. J., Braghetta, P., & Rampazzo, A. (2017) · Oncotarget · doi:10.18632/oncotarget.17457 · Cited by 64
Zheng, G., Jiang, C., Li, Y., Yang, D., Ma, Y., Zhang, B., Li, X., Zhang, P., Hu, X., Zhao, X., et al. (2019) · Protein & Cell · doi:10.1007/s13238-018-0563-2 · Cited by 48
Gao, S., Puthenvedu, D., Lombardi, R., & Chen, S. N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176320 · Cited by 28
“Inflammatory cellular infiltrates have been detected in the heart in over 70% of ARVC patients and in ACM mouse models [2,4,22,34,132].”
BackgroundVanaja, I. P., Scalco, A., Ronfini, M., Bona, A. D., Olianti, C., Rizzo, S., Chelko, S. P., Corrado, D., Sacconi, L., Basso, C., et al. (2025) · The Journal of Physiology · doi:10.1113/jp286845 · Cited by 17
Metadata
- Authors
- Li, J., Swope, D., Raess, N., Cheng, L., Muller, E. J., & Radice, G. L.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2011-03-01
- Volume
- 31
- Issue
- 6
- Pages
- 1134-1144
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W2096813390
- Cited by
- 131
- References
- 6
- FWCI
- 8.20
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.